{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "Stephanie Clifford contributed reporting.", "original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Turing Pharmaceuticals says Martin Shkreli has resigned as chief executive after his arrest on securities fraud charges; Ron Tilles will be interim chief executive and remain chairman.", "type_of_material": "News", "word_count": "1053", "lead_paragraph": "Mr. Shkreli was charged with fraud this week related to activities at a hedge fund he ran and at an earlier pharmaceutical company.", "pub_date": "2015-12-19T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Martin Shkreli Resigns From Turing Pharmaceuticals", "print_headline": "Chief of Turing Pharmaceuticals Resigns After Arrest"}, "snippet": "Mr. Shkreli was charged with fraud this week related to activities at a hedge fund he ran and at an earlier pharmaceutical company.", "multimedia": [{"height": 126, "url": "images/2015/12/19/business/19turingweb1/19turingweb1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/12/19/business/19turingweb1/19turingweb1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/12/19/business/19turingweb1/19turingweb1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/12/19/business/19turingweb1/19turingweb1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/12/19/business/19turingweb1/19turingweb1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/12/19/business/19turingweb1/19turingweb1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/19/business/martin-shkreli-resigns-turing-drug-company.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "3", "is_major": "Y", "value": "Tilles, Ron (1958- )", "name": "persons"}, {"rank": "4", "is_major": "Y", "value": "Securities and Commodities Violations", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Appointments and Executive Changes", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Retrophin Inc", "name": "organizations"}], "blog": [], "_id": "5674483a38f0d805d002ea1d", "source": "The New York Times"}